Date & Time: Tuesday, March 31, 2020 1:00pm-2:30pm EDT
Details: Panitch Schwarze partners, Travis W. Bliss, Ph.D., Erin M. Dunston and Philip L. Hirschhorn, will present on the interplay between Paragraph IV litigation and IPRs, multiple generic challengers, and key issues in IPRs in a Strafford 90-minute webinar.
They will guide counsel on pharmaceutical-related patent challenges from strategy to settlement. The presenters will also examine critical issues in Inter partes review (IPR) challenges involving pharmaceutical patents. Finally, they will discuss new risks to settlement in light of the changing landscape surrounding antitrust review of pharmaceutical patent settlements.
The presenters will review these and other key issues:
- Where do multiple generic challengers fit into the exclusivity scheme?
- How do pharmaceutical patents fare in post-grant challenges in comparison to all patents?
- What are the crucial issues in post-grant challenges involving pharmaceutical patents?
- What are potential strategies for pharmaceutical companies looking to settle and mitigate risk?
Strafford carefully selects leaders in their fields to provide continuing legal education webinars on the most current and relevant issues. This continuing legal education event can be viewed live or on-demand after the event. Click here to register.
About Panitch Schwarze Belisario & Nadel LLP – Panitch Schwarze Belisario & Nadel LLP is a boutique intellectual property law firm with offices in Philadelphia and Wilmington, Delaware. The firm’s IP law practitioners provide strategic litigation, licensing and counseling service relating to patents, trademarks, copyrights and trade secrets, domain names and internet issues domestically and internationally. The firm’s long-standing relationships with a network of associates worldwide enable its attorneys and advisors to provide clients with global intellectual property advice and protection.